{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T06:34:09Z","timestamp":1751438049618},"reference-count":155,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["EMIDDT"],"published-print":{"date-parts":[[2020,1,7]]},"abstract":"<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>Thyroid Hormones (TH) are essential for normal growth, development and continued\noptimal function of most of the body organs including the eye. TH signaling plays a central role\nin the regulation of retinal development and maturation. Deficiency in TH during fetal and early postnatal\ndevelopment impairs growth of the eye and proliferation of all retinal cell types. The present\narticle reviews the most important topics of the different derangements in thyroid function and structure\nand its relation with eye diseases.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>A literature search strategy was conducted for all English-language literature.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>From a clinical practice viewpoint, it should be mentioned that both hypothyroidism and hyperthyroidism\nare accompanied by ocular diseases i.e. thyroid-associated ophthalmopathy, diabetic\nretinopathy and age-related macular degeneration. Although the orbit and globe are not common sites\nfor metastatic thyroid cancers, orbital metastasis may be the primary clinical manifestation of thyroid\ncarcinoma. Finally, some medications as amiodarone may be accompanied by both thyroid dysfunction\nand adverse ocular events.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Thyroid disorders and eye diseases are interrelated through several mechanisms thus,\nawareness of this relation has a great impact on early diagnosis and treatment.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871530319666190618120107","type":"journal-article","created":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T09:35:48Z","timestamp":1561628148000},"page":"39-49","update-policy":"http:\/\/dx.doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Thyroid and Eye: Where They Meet in Clinical Practice"],"prefix":"10.2174","volume":"20","author":[{"given":"Mervat M.","family":"El-Eshmawy","sequence":"first","affiliation":[{"name":"Internal Medicine Department, Mansoura Specialized Medical Hospital, Faculty of Medicine, Mansoura University, Mansoura, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maha","family":"Shahin","sequence":"additional","affiliation":[{"name":"Ophthalmology Department, Mansoura Ophthalmic Center, Faculty of Medicine, Mansoura University, Mansoura, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1089\/thy.2007.0266","volume":"18","author":"Kim B.","year":"2008","unstructured":"Kim B.; Thyroid hormone as a determinant of energy expenditure and the basal metabolic rate. Thyroid 2008,18(2),141-144","journal-title":"Thyroid"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"U25","DOI":"10.1530\/eje.0.151u025","volume":"151","author":"Morreale de Escobar G.","year":"2004","unstructured":"Morreale de Escobar G.; Obregon M.J.; Escobar del Rey F.; Role of thyroid hormone during early brain development. Eur J Endocrinol 2004,151(Suppl. 3),U25-U37","journal-title":"Eur J Endocrinol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1677\/JOE-08-0218","volume":"199","author":"Wagner M.S.","year":"2008","unstructured":"Wagner M.S.; Wajner S.M.; Maia A.L.; The role of thyroid hormone in testicular development and function. J Endocrinol 2008,199(3),351-365","journal-title":"J Endocrinol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1001\/archinte.160.4.526","volume":"160","author":"Canaris G.J.","year":"2000","unstructured":"Canaris G.J.; Manowitz N.R.; Mayor G.; Ridgway E.C.; The Colorado thyroid disease prevalence study. Arch Intern Med 2000,160(4),526-534","journal-title":"Arch Intern Med"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1089\/thy.2006.0235","volume":"17","author":"Aoki Y.","year":"2007","unstructured":"Aoki Y.; Belin R.M.; Clickner R.; Jeffries R.; Phillips L.; Mahaffey K.R.; Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002). Thyroid 2007,17(12),1211-1223","journal-title":"Thyroid"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1210\/jc.2013-2409","volume":"99","author":"Garmendia Madariaga A.","year":"2014","unstructured":"Garmendia Madariaga A.; Santos Palacios S.; Guill\u00e9n-Grima F.; Galofr\u00e9 J.C.; The incidence and prevalence of thyroid dysfunction in Europe: a meta-analysis. J Clin Endocrinol Metab 2014,99(3),923-931","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"6218","DOI":"10.1073\/pnas.0509981103","volume":"103","author":"Roberts M.R.","year":"2006","unstructured":"Roberts M.R.; Srinivas M.; Forrest D.; Morreale de Escobar G.; Reh T.A.; Making the gradient: thyroid hormone regulates cone opsin expression in the developing mouse retina. Proc Natl Acad Sci USA 2006,103(16),6218-6223","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"4844","DOI":"10.1523\/JNEUROSCI.6181-10.2011","volume":"31","author":"Glaschke A.","year":"2011","unstructured":"Glaschke A.; Weiland J.; Del Turco D.; Steiner M.; Peichl L.; Gl\u00f6smann M.; Thyroid hormone controls cone opsin expression in the retina of adult rodents. J Neurosci 2011,31(13),4844-4851","journal-title":"J Neurosci"},{"key":"ref=9","first-page":"331","volume":"17","author":"Vangheluwe O.","year":"1994","unstructured":"Vangheluwe O.; Ducasse A.; Vaudrey C.; Maes B.; Delisle M.J.; [Prevalence of ophthalmopathy in Basedow disease. Follow-up of patients one year following diagnosis of hyperthyroidism] J Fr Ophtalmol 1994,17(5),331-338","journal-title":"J Fr Ophtalmol"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"12212","DOI":"10.1038\/srep12212","volume":"20","author":"Wu J.","year":"2015","unstructured":"Wu J.; Yue S.; Geng J.; Liu L.; Teng W.; Liu L.; Chen L.; Relationship between Diabetic Retinopathy and SubclinicalHypothyroidism: a meta-analysis. Sci Rep 2015,20(5),12212","journal-title":"Sci Rep"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12916-015-0329-0","volume":"13","author":"Chaker L.","year":"2015","unstructured":"Chaker L.; Buitendijk G.H.; Dehghan A.; Medici M.; Hofman A.; Vingerling J.R.; Franco O.H.; Klaver C.C.; Peeters R.P.; Thyroid function and age-related macular degeneration: a prospective population-based cohort study--the Rotterdam Study. BMC Med 2015,13,94","journal-title":"BMC Med"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1590\/S0004-27302008000900014","volume":"52","author":"Rocha Filho F.D.","year":"2008","unstructured":"Rocha Filho F.D.; Lima G.G.; Ferreira F.V.; Lima M.G.; Hissa M.N.; Orbital metastasis as primary clinical manifestation of thyroid carcinoma--case report and literature review. Arq Bras Endocrinol Metabol 2008,52(9),1497-1500","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"ref=13","first-page":"340","volume":"35","author":"Bogazzi F.","year":"2012","unstructured":"Bogazzi F.; Tomisti L.; Bartalena L.; Aghini-Lombardi F.; Martino E.; Amiodarone and the thyroid: a 2012 update. J Endocrinol Invest 2012,35(3),340-348","journal-title":"J Endocrinol Invest"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1097\/01.ICL.0000165283.36659.35","volume":"31","author":"U\u00e7akhan O.O.","year":"2005","unstructured":"U\u00e7akhan O.O.; Kanpolat A.; Ylmaz N.; Ozkan M.; Amiodarone keratopathy: an in vivo confocal microscopy study. Eye Contact Lens 2005,31(4),148-157","journal-title":"Eye Contact Lens"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1172\/JCI60047","volume":"122","author":"Brent G.A.","year":"2012","unstructured":"Brent G.A.; Mechanisms of thyroid hormone action. J Clin Invest 2012,122(9),3035-3043","journal-title":"J Clin Invest"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1124\/pr.58.4.3","volume":"58","author":"Flamant F.","year":"2006","unstructured":"Flamant F.; Baxter J.D.; Forrest D.; Refetoff S.; Samuels H.; Scanlan T.S.; Vennstr\u00f6m B.; Samarut J.; International Union of Pharmacology. LIX. The pharmacology and classification of the nuclear receptor superfamily: thyroid hormone receptors. Pharmacol Rev 2006,58(4),705-711","journal-title":"Pharmacol Rev"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1002\/ar.a.20262","volume":"287","author":"Peichl L.","year":"2005","unstructured":"Peichl L.; Diversity of mammalian photoreceptor properties: adaptations to habitat and lifestyle? Anat Rec A Discov Mol Cell Evol Biol 2005,287(1),1001-1012","journal-title":"Anat Rec A Discov Mol Cell Evol Biol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1097\/WNR.0b013e32832a2c63","volume":"20","author":"Ng L.","year":"2009","unstructured":"Ng L.; Ma M.; Curran T.; Forrest D.; Developmental expression of thyroid hormone receptor \u03b22 protein in cone photoreceptors in the mouse. Neuroreport 2009,20(6),627-631","journal-title":"Neuroreport"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"5590","DOI":"10.1167\/iovs.06-0063","volume":"47","author":"Lee T.C.","year":"2006","unstructured":"Lee T.C.; Almeida D.; Claros N.; Abramson D.H.; Cobrinik D.; Cell cycle-specific and cell type-specific expression of Rb in the developing human retina. Invest Ophthalmol Vis Sci 2006,47(12),5590-5598","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"14104","DOI":"10.1073\/pnas.0601600103","volume":"103","author":"Hiroi Y.","year":"2006","unstructured":"Hiroi Y.; Kim H.H.; Ying H.; Furuya F.; Huang Z.; Simoncini T.; Noma K.; Ueki K.; Nguyen N.H.; Scanlan T.S.; Moskowitz M.A.; Cheng S.Y.; Liao J.K.; Rapid nongenomic actions of thyroid hormone. Proc Natl Acad Sci USA 2006,103(38),14104-14109","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1210\/er.2009-0007","volume":"31","author":"Cheng S.Y.","year":"2010","unstructured":"Cheng S.Y.; Leonard J.L.; Davis P.J.; Molecular aspects of thyroid hormone actions. Endocr Rev 2010,31(2),139-170","journal-title":"Endocr Rev"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"8248","DOI":"10.1167\/iovs.15-17743","volume":"56","author":"Sawant O.","year":"2015","unstructured":"Sawant O.; Horton A.M.; Shukla M.; Rayborn M.E.; Peachey N.S.; Hollyfield J.G.; Rao S.; Light-Regulated Thyroid Hormone Signaling Is Required for Rod Photoreceptor Development in the Mouse Retina. Invest Ophthalmol Vis Sci 2015,56(13),8248-8257","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000063885","volume":"34","author":"Sevilla-Romero E.","year":"2002","unstructured":"Sevilla-Romero E.; Mu\u00f1oz A.; Pinazo-Dur\u00e1n M.D.; Low thyroid hormone levels impair the perinatal development of the rat retina. Ophthalmic Res 2002,34(4),181-191","journal-title":"Ophthalmic Res"},{"key":"ref=24","first-page":"731","volume":"171","author":"Newell F.W.","year":"1977","unstructured":"Newell F.W.; Diddie K.R.; [Typical monochromacy, congenital deafness, and resistance to intracellular action of thyroid hormone (author\u2019s transl)] Klin Monatsbl Augenheilkd 1977,171(5),731-734","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1530\/JOE-11-0002","volume":"209","author":"Dentice M.","year":"2011","unstructured":"Dentice M.; Salvatore D.; Deiodinases: the balance of thyroid hormone: local impact of thyroid hormone inactivation. J Endocrinol 2011,209(3),273-282","journal-title":"J Endocrinol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1523\/JNEUROSCI.5267-09.2010","volume":"30","author":"Ng L.","year":"2010","unstructured":"Ng L.; Lyubarsky A.; Nikonov S.S.; Ma M.; Srinivas M.; Kefas B.; St Germain D.L.; Hernandez A.; Pugh E.N.; Forrest D.; Type 3 deiodinase, a thyroid-hormone-inactivating enzyme, controls survival and maturation of cone photoreceptors. J Neurosci 2010,30(9),3347-3357","journal-title":"J Neurosci"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"3602","DOI":"10.1073\/pnas.1317041111","volume":"111","author":"Ma H.","year":"2014","unstructured":"Ma H.; Thapa A.; Morris L.; Redmond T.M.; Baehr W.; Ding X.Q.; Suppressing thyroid hormone signaling preserves cone photoreceptors in mouse models of retinal degeneration. Proc Natl Acad Sci USA 2014,111(9),3602-3607","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"4313","DOI":"10.1096\/fj.201600715R","volume":"30","author":"Yang F.","year":"2016","unstructured":"Yang F.; Ma H.; Belcher J.; Butler M.R.; Redmond T.M.; Boye S.L.; Hauswirth W.W.; Ding X.Q.; Targeting iodothyronine deiodinases locally in the retina is a therapeutic strategy for retinal degeneration. FASEB J 2016,30(12),4313-4325","journal-title":"FASEB J"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"3425","DOI":"10.1096\/fj.201601166RR","volume":"31","author":"Ma H.","year":"2017","unstructured":"Ma H.; Yang F.; Butler M.R.; Belcher J.; Redmond T.M.; Placzek A.T.; Scanlan T.S.; Ding X-Q.; Inhibition of thyroid hormone receptor locally in the retina is a therapeutic strategy for retinal degeneration. FASEB J 2017,31(8),3425-3438","journal-title":"FASEB J"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1083\/jcb.201305084","volume":"204","author":"Zambrano A.","year":"2014","unstructured":"Zambrano A.; Garc\u00eda-Carpizo V.; Gallardo M.E.; Villamuera R.; G\u00f3mez-Ferrer\u00eda M.A.; Pascual A.; Buisine N.; Sachs L.M.; Garesse R.; Aranda A.; The thyroid hormone receptor \u03b2 induces DNA damage and premature senescence. J Cell Biol 2014,204(1),129-146","journal-title":"J Cell Biol"},{"key":"ref=31","first-page":"302","volume":"3","author":"Park J.W.","year":"2013","unstructured":"Park J.W.; Zhao L.; Cheng S.Y.; Inhibition of estrogen-dependent tumorigenesis by the thyroid hormone receptor \u03b2 in xenograft models. Am J Cancer Res 2013,3(3),302-311","journal-title":"Am J Cancer Res"},{"key":"ref=32","author":"Werner S.C.","year":"1996","unstructured":"Werner S.C.; Ingbar S.H.; Braverman L.E.; Utiger R.D.;  The Thyroid: A Fundamental and Clinical Text 1996","journal-title":"The Thyroid: A Fundamental and Clinical Text"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/S0161-6420(96)30579-4","volume":"103","author":"Bartley G.B.","year":"1996","unstructured":"Bartley G.B.; Fatourechi V.; Kadrmas E.F.; Jacobsen S.J.; Ilstrup D.M.; Garrity J.A.; Gorman C.A.; Long-term follow-up of Graves ophthalmopathy in an incidence cohort. Ophthalmology 1996,103(6),958-962","journal-title":"Ophthalmology"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/ICU.0b013e3283499446","volume":"22","author":"Douglas R.S.","year":"2011","unstructured":"Douglas R.S.; Gupta S.; The pathophysiology of thyroid eye disease: implications for immunotherapy. Curr Opin Ophthalmol 2011,22(5),385-390","journal-title":"Curr Opin Ophthalmol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S0002-9394(02)01390-9","volume":"133","author":"Kalmann R.","year":"2002","unstructured":"Kalmann R.; Mourits M.P.; Late recurrence of unilateral graves orbitopathy on the contralateral side. Am J Ophthalmol 2002,133(5),727-729","journal-title":"Am J Ophthalmol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1210\/edrv-10-3-366","volume":"10","author":"Smith T.J.","year":"1989","unstructured":"Smith T.J.; Bahn R.S.; Gorman C.A.; Connective tissue, glycosaminoglycans, and diseases of the thyroid. Endocr Rev 1989,10(3),366-391","journal-title":"Endocr Rev"},{"key":"ref=37","first-page":"518","author":"Davies T.F.","year":"2000","unstructured":"Davies T.F.; Graves\u2019 disease: Pathogenesis. Werner  2000,518","journal-title":"Werner"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/j.1365-2265.1993.tb00516.x","volume":"38","author":"Perros P.","year":"1993","unstructured":"Perros P.; Crombie A.L.; Matthews J.N.; Kendall-Taylor P.; Age and gender influence the severity of thyroid-associated ophthalmopathy: a study of 101 patients attending a combined thyroid-eye clinic. Clin Endocrinol (Oxf) 1993,38(4),367-372","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1001\/jama.1993.03500040045034","volume":"269","author":"Prummel M.F.","year":"1993","unstructured":"Prummel M.F.; Wiersinga W.M.; Smoking and risk of Graves\u2019 disease. JAMA 1993,269(4),479-482","journal-title":"JAMA"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1111\/j.1365-2265.2008.03279.x","volume":"69","author":"Acharya S.H.","year":"2008","unstructured":"Acharya S.H.; Avenell A.; Philip S.; Burr J.; Bevan J.S.; Abraham P.; Radioiodine therapy (RAI) for Graves\u2019 disease (GD) and the effect on ophthalmopathy: a systematic review. Clin Endocrinol (Oxf) 2008,69(6),943-950","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"318","DOI":"10.20452\/pamw.400","volume":"118","author":"Grzesiuk W.","year":"2008","unstructured":"Grzesiuk W.; Szydlarska D.; Pragacz A.; Bar-Andziak E.; Thyroid-associated orbitopathy in patients with Hashimoto\u2019s thyroiditis: a case report. Pol Arch Med Wewn 2008,118(5),318-321","journal-title":"Pol Arch Med Wewn"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"262","DOI":"10.4274\/jcrpe.1450","volume":"6","author":"K\u0131rm\u0131z\u0131bekmez H.","year":"2014","unstructured":"K\u0131rm\u0131z\u0131bekmez H.; Ye\u015filtepe Mutlu R.G.; Dursun F.; Gunay M.; Atypical Presentation of Hashimoto\u2019s Disease in an Adolescent: Thyroid-Associated Ophthalmopathy. J Clin Res Pediatr Endocrinol 2014,6(4),262-265","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1056\/NEJMra0905750","volume":"362","author":"Bahn R.S.","year":"2010","unstructured":"Bahn R.S.; Graves\u2019 ophthalmopathy. N Engl J Med 2010,362(8),726-738","journal-title":"N Engl J Med"},{"key":"ref=44","first-page":"747","volume":"14","author":"Burch H.B.","year":"1993","unstructured":"Burch H.B.; Wartofsky L.; Graves\u2019 ophthalmopathy: current concepts regarding pathogenesis and management. Endocr Rev 1993,14(6),747-793","journal-title":"Endocr Rev"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1089\/thy.1997.7.3","volume":"7","author":"Stadlmayr W.","year":"1997","unstructured":"Stadlmayr W.; Spitzweg C.; Bichlmair A.M.; Heufelder A.E.; TSH receptor transcripts and TSH receptor-like immunoreactivity in orbital and pretibial fibroblasts of patients with Graves\u2019 ophthalmopathy and pretibial myxedema. Thyroid 1997,7(1),3-12","journal-title":"Thyroid"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1530\/eje.0.1360599","volume":"136","author":"Spitzweg C.","year":"1997","unstructured":"Spitzweg C.; Joba W.; Hunt N.; Heufelder A.E.; Analysis of human thyrotropin receptor gene expression and immunoreactivity in human orbital tissue. Eur J Endocrinol 1997,136(6),599-607","journal-title":"Eur J Endocrinol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1210\/jc.84.7.2557","volume":"84","author":"Valyasevi R.W.","year":"1999","unstructured":"Valyasevi R.W.; Erickson D.Z.; Harteneck D.A.; Dutton C.M.; Heufelder A.E.; Jyonouchi S.C.; Bahn R.S.; Differentiation of human orbital preadipocyte fibroblasts induces expression of functional thyrotropin receptor. J Clin Endocrinol Metab 1999,84(7),2557-2562","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"4397","DOI":"10.4049\/jimmunol.181.6.4397","volume":"181","author":"Tsui S.","year":"2008","unstructured":"Tsui S.; Naik V.; Hoa N.; Hwang C.J.; Afifiyan N.F.; Sinha Hikim A.; Gianoukakis A.G.; Douglas R.S.; Smith T.J.; Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves\u2019 disease. J Immunol 2008,181(6),4397-4405","journal-title":"J Immunol"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.beem.2011.11.005","volume":"26","author":"Marcocci C.","year":"2012","unstructured":"Marcocci C.; Marin\u00f2 M.; Treatment of mild, moderate-to-severe and very severe Graves\u2019 orbitopathy. Best Pract Res Clin Endocrinol Metab 2012,26(3),325-337","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1001\/archopht.1980.01020040625007","volume":"98","author":"Skalka H.W.","year":"1980","unstructured":"Skalka H.W.; Prchal J.T.; Effect of corticosteroids on cataract formation. Arch Ophthalmol 1980,98(10),1773-1777","journal-title":"Arch Ophthalmol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"439","DOI":"10.2165\/00002512-199915060-00004","volume":"15","author":"Tripathi R.C.","year":"1999","unstructured":"Tripathi R.C.; Parapuram S.K.; Tripathi B.J.; Zhong Y.; Chalam K.V.; Corticosteroids and glaucoma risk. Drugs Aging 1999,15(6),439-450","journal-title":"Drugs Aging"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"988","DOI":"10.4158\/EP12280.GL","volume":"18","author":"Garber J.R.","year":"2012","unstructured":"Garber J.R.; Cobin R.H.; Gharib H.; Hennessey J.V.; Klein I.; Mechanick J.I.; Pessah-Pollack R.; Singer P.A.; Woeber K.A.; American Association of Clinical Endocrinologists and American Thyroid Association Taskforce on Hypothyroidism in Adults. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract 2012,18(6),988-1028","journal-title":"Endocr Pract"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/j.1464-5491.1995.tb00553.x","volume":"12","author":"Perros P.","year":"1995","unstructured":"Perros P.; McCrimmon R.J.; Shaw G.; Frier B.M.; Frequency of thyroid dysfunction in diabetic patients: value of annual screening. Diabet Med 1995,12(7),622-627","journal-title":"Diabet Med"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1507\/endocrj.K06-124","volume":"54","author":"Uzunlulu M.","year":"2007","unstructured":"Uzunlulu M.; Yorulmaz E.; Oguz A.; Prevalence of subclinical hypothyroidism in patients with metabolic syndrome. Endocr J 2007,54(1),71-76","journal-title":"Endocr J"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.amjmed.2009.12.023","volume":"123","author":"Jones D.D.","year":"2010","unstructured":"Jones D.D.; May K.E.; Geraci S.A.; Subclinical thyroid disease. Am J Med 2010,123(6),502-504","journal-title":"Am J Med"},{"key":"ref=56","first-page":"96","volume":"35","author":"La Vignera S.","year":"2012","unstructured":"La Vignera S.; Condorelli R.; Vicari E.; Calogero A.E.; Endothelial dysfunction and subclinical hypothyroidism: a brief review. J Endocrinol Invest 2012,35(1),96-103","journal-title":"J Endocrinol Invest"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1210\/jcem.87.4.8378","volume":"87","author":"Caraccio N.","year":"2002","unstructured":"Caraccio N.; Ferrannini E.; Monzani F.; Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebo-controlled study. J Clin Endocrinol Metab 2002,87(4),1533-1538","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3109\/09286580903450346","volume":"17","author":"Yamada M.","year":"2010","unstructured":"Yamada M.; Hiratsuka Y.; Roberts C.B.; Pezzullo M.L.; Yates K.; Takano S.; Miyake K.; Taylor H.R.; Prevalence of visual impairment in the adult Japanese population by cause and severity and future projections. Ophthalmic Epidemiol 2010,17(1),50-57","journal-title":"Ophthalmic Epidemiol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1001\/jama.2010.1111","volume":"304","author":"Zhang X.","year":"2010","unstructured":"Zhang X.; Saaddine J.B.; Chou C.F.; Cotch M.F.; Cheng Y.J.; Geiss L.S.; Gregg E.W.; Albright A.L.; Klein B.E.; Klein R.; Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA 2010,304(6),649-656","journal-title":"JAMA"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1620\/tjem.222.303","volume":"222","author":"Yang G.R.","year":"2010","unstructured":"Yang G.R.; Yang J.K.; Zhang L.; An Y.H.; Lu J.K.; Association between subclinical hypothyroidism and proliferative diabetic retinopathy in type 2 diabetic patients: a case-control study. Tohoku J Exp Med 2010,222(4),303-310","journal-title":"Tohoku J Exp Med"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.2337\/dc09-1784","volume":"33","author":"Yang J.K.","year":"2010","unstructured":"Yang J.K.; Liu W.; Shi J.; Li Y.B.; An association between subclinical hypothyroidism and sight-threatening diabetic retinopathy in type 2 diabetic patients. Diabetes Care 2010,33(5),1018-1020","journal-title":"Diabetes Care"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1507\/endocrj.EJ11-0199","volume":"58","author":"Kim B.Y.","year":"2011","unstructured":"Kim B.Y.; Kim C.H.; Jung C.H.; Mok J.O.; Suh K.I.; Kang S.K.; Association between subclinical hypothyroidism and severe diabetic retinopathy in Korean patients with type 2 diabetes. Endocr J 2011,58(12),1065-1070","journal-title":"Endocr J"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1016\/j.diabres.2012.05.015","volume":"97","author":"Ramis J.N.","year":"2012","unstructured":"Ramis J.N.; Artigas C.F.; Santiago M.A.; Ma\u00f1es F.J.; Canonge R.S.; Comas L.M.; Is there a relationship between TSH levels and diabetic retinopathy in the Caucasian population? Diabetes Res Clin Pract 2012,97(3),e45-e47","journal-title":"Diabetes Res Clin Pract"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1111\/j.1464-5491.2007.02270.x","volume":"24","author":"Chen H.S.","year":"2007","unstructured":"Chen H.S.; Wu T.E.; Jap T.S.; Lu R.A.; Wang M.L.; Chen R.L.; Lin H.D.; Subclinical hypothyroidism is a risk factor for nephropathy and cardiovascular diseases in Type 2 diabetic patients. Diabet Med 2007,24(12),1336-1344","journal-title":"Diabet Med"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.12659\/MSM.902006","volume":"23","author":"Qi Q.","year":"2017","unstructured":"Qi Q.; Zhang Q.M.; Li C.J.; Dong R.N.; Li J.J.; Shi J.Y.; Yu D.M.; Zhang J.Y.; Association of Thyroid-Stimulating Hormone Levels with Microvascular Complications in Type 2 Diabetes Patients. Med Sci Monit 2017,23(23),2715-2720","journal-title":"Med Sci Monit"},{"key":"ref=66","first-page":"235","volume":"47","author":"Popescu T.","year":"2009","unstructured":"Popescu T.; Mo\u0163a M.; Dyslipidemia and hypertension in patients with type 2 diabetes and retinopathy. Rom J Intern Med 2009,47(3),235-241","journal-title":"Rom J Intern Med"},{"key":"ref=67","first-page":"721","volume":"75","author":"Masaki H.","year":"1992","unstructured":"Masaki H.; Nishikawa M.; Urakami M.; Yoshimura M.; Toyoda N.; Mori Y.; Yoshikawa N.; Inada M.; 3,3\u2032,5\u2032-Triiodothyronine inhibits collagen-induced human platelet aggregation. J Clin Endocrinol Metab 1992,75(3),721-725","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=68","first-page":"760","volume":"35","author":"Ishikawa T.","year":"1989","unstructured":"Ishikawa T.; Chijiwa T.; Hagiwara M.; Mamiya S.; Hidaka H.; Thyroid hormones directly interact with vascular smooth muscle strips. Mol Pharmacol 1989,35(6),760-765","journal-title":"Mol Pharmacol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1055\/s-0037-1614228","volume":"79","author":"Chadarevian R.","year":"1998","unstructured":"Chadarevian R.; Bruckert E.; Ankri A.; Beucler I.; Giral P.; Turpin G.; Relationship between thyroid hormones and plasma D-dimer levels. Thromb Haemost 1998,79(1),99-103","journal-title":"Thromb Haemost"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/BF03350150","volume":"11","author":"K\u00f6ltringer P.","year":"1988","unstructured":"K\u00f6ltringer P.; Eber O.; Wakonig P.; Klima G.; Lind P.; Hypothyroidism and the influence on human blood rheology. J Endocrinol Invest 1988,11(4),267-272","journal-title":"J Endocrinol Invest"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1530\/EJE-08-0797","volume":"160","author":"Maratou E.","year":"2009","unstructured":"Maratou E.; Hadjidakis D.J.; Kollias A.; Tsegka K.; Peppa M.; Alevizaki M.; Mitrou P.; Lambadiari V.; Boutati E.; Nikzas D.; Tountas N.; Economopoulos T.; Raptis S.A.; Dimitriadis G.; Studies of insulin resistance in patients with clinical and subclinical hypothyroidism. Eur J Endocrinol 2009,160(5),785-790","journal-title":"Eur J Endocrinol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.2337\/diacare.27.11.2661","volume":"27","author":"Hadjadj S.","year":"2004","unstructured":"Hadjadj S.; P\u00e9an F.; Gallois Y.; Passa P.; Aubert R.; Weekers L.; Rigalleau V.; Bauduceau B.; Bekherraz A.; Roussel R.; Dussol B.; Rodier M.; Marechaud R.; Lefebvre P.J.; Marre M.; Genesis France-Belgium Study. Different patterns of insulin resistance in relatives of type 1 diabetic patients with retinopathy or nephropathy: the Genesis France-Belgium Study. Diabetes Care 2004,27(11),2661-2668","journal-title":"Diabetes Care"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"4371","DOI":"10.1210\/jc.2003-032076","volume":"89","author":"Parvanova A.","year":"2004","unstructured":"Parvanova A.; Iliev I.; Filipponi M.; Dimitrov B.D.; Vedovato M.; Tiengo A.; Trevisan R.; Remuzzi G.; Ruggenenti P.; Insulin resistance and proliferative retinopathy: a cross-sectional, case-control study in 115 patients with type 2 diabetes. J Clin Endocrinol Metab 2004,89(9),4371-4376","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"C25","DOI":"10.1507\/endocrj.47.77","volume":"22","author":"Yudkin J.S.","year":"1999","unstructured":"Yudkin J.S.; Abnormalities of coagulation and fibrinolysis in insulin\nresistance. Evidence for a common antecedent? Diabetes Care 1999,22(Suppl 3),C25-30. 26","journal-title":"Evidence for a common antecedent? Diabetes Care"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1507\/endocrj.47.77","volume":"47","author":"Kurioka S.","year":"2000","unstructured":"Kurioka S.; Koshimura K.; Murakami Y.; Nishiki M.; Kato Y.; Reverse correlation between urine nitric oxide metabolites and insulin resistance in patients with type 2 diabetes mellitus. Endocr J 2000,47(1),77-81","journal-title":"Endocr J"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1089\/1050725041692891","volume":"14","author":"Cikim A.S.","year":"2004","unstructured":"Cikim A.S.; Oflaz H.; Ozbey N.; Cikim K.; Umman S.; Meric M.; Sencer E.; Molvalilar S.; Evaluation of endothelial function in subclinical hypothyroidism and subclinical hyperthyroidism. Thyroid 2004,14(8),605-609","journal-title":"Thyroid"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1056\/NEJMra0801537","volume":"358","author":"Jager R.D.","year":"2008","unstructured":"Jager R.D.; Mieler W.F.; Miller J.W.; Age-related macular degeneration. N Engl J Med 2008,358(24),2606-2617","journal-title":"N Engl J Med"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/S1350-9462(01)00010-6","volume":"20","author":"Hageman G.S.","year":"2001","unstructured":"Hageman G.S.; Luthert P.J.; Victor Chong N.H.; Johnson L.V.; Anderson D.H.; Mullins R.F.; An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch\u2019s membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res 2001,20(6),705-732","journal-title":"Prog Retin Eye Res"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00109-008-0418-z","volume":"87","author":"Kaarniranta K.","year":"2009","unstructured":"Kaarniranta K.; Salminen A.; Age-related macular degeneration: activation of innate immunity system via pattern recognition receptors. J Mol Med (Berl) 2009,87(2),117-123","journal-title":"J Mol Med (Berl)"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1056\/NEJMoa054481","volume":"355","author":"Rosenfeld P.J.","year":"2006","unstructured":"Rosenfeld P.J.; Brown D.M.; Heier J.S.; Boyer D.S.; Kaiser P.K.; Chung C.Y.; Kim R.Y.; Ranibizumab for neovascular age-related macular degeneration. N Engl J Med MARINA Study Group2006,355(14),1419-1431","journal-title":"N Engl J Med"},{"key":"ref=81","first-page":"343","volume":"15","author":"Nguyen D.H.","year":"2013","unstructured":"Nguyen D.H.; Luo J.; Zhang K.; Zhang M.; Current therapeutic approaches in neovascular age-related macular degeneration. Discov Med 2013,15(85),343-348","journal-title":"Discov Med"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/sj.eye.6701978","volume":"19","author":"Thornton J.","year":"2005","unstructured":"Thornton J.; Edwards R.; Mitchell P.; Harrison R.A.; Buchan I.; Kelly S.P.; Smoking and age-related macular degeneration: a review of association. Eye (Lond) 2005,19(9),935-944","journal-title":"Eye (Lond)"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1001\/jama.2013.4997","volume":"309","year":"2013","unstructured":"Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA Age-Related Eye Disease Study 2 Research Group2013,309(19),2005-2015","journal-title":"JAMA"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/S0140-6736(12)60282-7","volume":"379","author":"Lim L.S.","year":"2012","unstructured":"Lim L.S.; Mitchell P.; Seddon J.M.; Holz F.G.; Wong T.Y.; Age-related macular degeneration. Lancet 2012,379(9827),1728-1738","journal-title":"Lancet"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1017\/S000711451300408X","volume":"111","author":"Gopinath B.","year":"2014","unstructured":"Gopinath B.; Flood V.M.; Louie J.C.; Wang J.J.; Burlutsky G.; Rochtchina E.; Mitchell P.; Consumption of dairy products and the 15-year incidence of age-related macular degeneration. Br J Nutr 2014,111(9),1673-1679","journal-title":"Br J Nutr"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"549","DOI":"10.3109\/02713683.2011.647223","volume":"37","author":"Bromfield S.","year":"2012","unstructured":"Bromfield S.; Keenan J.; Jolly P.; McGwin G.; Jr A suggested association between hypothyroidism and age-related macular degeneration. Curr Eye Res 2012,37(6),549-552","journal-title":"Curr Eye Res"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1001\/archopht.119.9.1354","volume":"119","author":"Klein R.","year":"2001","unstructured":"Klein R.; Klein B.E.; Jensen S.C.; Cruickshanks K.J.; Lee K.E.; Danforth L.G.; Tomany S.C.; Medication use and the 5-year incidence of early age-related maculopathy: the Beaver Dam Eye Study. Arch Ophthalmol 2001,119(9),1354-1359","journal-title":"Arch Ophthalmol"},{"key":"ref=88","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/S0161-6420(00)00409-7","volume":"107","year":"2000","unstructured":"Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3. Ophthalmology Age-Related Eye Disease Study Research Group2000,107(12),2224-2232","journal-title":"Ophthalmology"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.ophtha.2006.09.018","volume":"114","author":"Douglas I.J.","year":"2007","unstructured":"Douglas I.J.; Cook C.; Chakravarthy U.; Hubbard R.; Fletcher A.E.; Smeeth L.; A case-control study of drug risk factors for age-related macular degeneration. Ophthalmology 2007,114(6),1164-1169","journal-title":"Ophthalmology"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"5273","DOI":"10.1167\/iovs.16-19735","volume":"1,57","author":"Gopinath B.","year":"2016","unstructured":"Gopinath B.; Liew G.; Kifley A.; Mitchell P.; Thyroid Dysfunction and Ten-Year Incidence of Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci 2016,1,57(13),5273-5277","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1001\/archopht.125.12.1652","volume":"125","author":"Tsai C.C.","year":"2007","unstructured":"Tsai C.C.; Kao S.C.; Cheng C.Y.; Kau H.C.; Hsu W.M.; Lee C.F.; Wei Y.H.; Oxidative stress change by systemic corticosteroid treatment among patients having active graves ophthalmopathy. Arch Ophthalmol 2007,125(12),1652-1656","journal-title":"Arch Ophthalmol"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1677\/joe.0.1450131","volume":"145","author":"Mano T.","year":"1995","unstructured":"Mano T.; Sinohara R.; Sawai Y.; Oda N.; Nishida Y.; Mokuno T.; Kotake M.; Hamada M.; Masunaga R.; Nakai A.; Nagasaka A.; Effects of thyroid hormone on coenzyme Q and other free radical scavengers in rat heart muscle. J Endocrinol 1995,145(1),131-136","journal-title":"J Endocrinol"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0039-6257(00)00140-5","volume":"45","author":"Beatty S.","year":"2000","unstructured":"Beatty S.; Koh H.; Phil M.; Henson D.; Boulton M.; The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 2000,45(2),115-134","journal-title":"Surv Ophthalmol"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1159\/000055564","volume":"31","author":"Duncan K.G.","year":"1999","unstructured":"Duncan K.G.; Bailey K.R.; Baxter J.D.; Schwartz D.M.; The human fetal retinal pigment epithelium: A target tissue for thyroid hormones. Ophthalmic Res 1999,31(6),399-406","journal-title":"Ophthalmic Res"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1161\/CIRCULATIONAHA.106.678326","volume":"116","author":"Klein I.","year":"2007","unstructured":"Klein I.; Danzi S.; Thyroid disease and the heart. Circulation 2007,116(15),1725-1735","journal-title":"Circulation"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.ecl.2007.04.008","volume":"36","author":"Devdhar M.","year":"2007","unstructured":"Devdhar M.; Ousman Y.H.; Burman K.D.; Hypothyroidism. Endocrinol Metab Clin North Am  v. [v.].2007,36(3),595-615","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/oxfordjournals.epirev.a036198","volume":"17","author":"Vingerling J.R.","year":"1995","unstructured":"Vingerling J.R.; Klaver C.C.; Hofman A.; de Jong P.T.; Epidemiology of age-related maculopathy. Epidemiol Rev 1995,17(2),347-360","journal-title":"Epidemiol Rev"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"902","DOI":"10.3390\/ijerph15050902","volume":"15","author":"Lin S.Y.","year":"2018","unstructured":"Lin S.Y.; Hsu W.H.; Lin C.L.; Lin C.C.; Lin J.M.; Chang Y.L.; Hsu C.Y.; Kao C.H.; Evidence for an Association between Macular Degeneration and Thyroid Cancer in the Aged Population. Int J Environ Res Public Health 2018,15(5),902","journal-title":"Int J Environ Res Public Health"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1177\/030006051204000601","volume":"40","author":"Zhao Z.G.","year":"2012","unstructured":"Zhao Z.G.; Guo X.G.; Ba C.X.; Wang W.; Yang Y.Y.; Wang J.; Cao H.Y.; Overweight, obesity and thyroid cancer risk: a meta-analysis of cohort studies. J Int Med Res 2012,40(6),2041-2050","journal-title":"J Int Med Res"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1001\/archopht.121.6.785","volume":"121","author":"Seddon J.M.","year":"2003","unstructured":"Seddon J.M.; Cote J.; Davis N.; Rosner B.; Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio. Arch Ophthalmol 2003,121(6),785-792","journal-title":"Arch Ophthalmol"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"4647","DOI":"10.1038\/sj.onc.1209607","volume":"25","author":"Brandon M.","year":"2006","unstructured":"Brandon M.; Baldi P.; Wallace D.C.; Mitochondrial mutations in cancer. Oncogene 2006,25(34),4647-4662","journal-title":"Oncogene"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.1167\/iovs.08-2646","volume":"50","author":"Udar N.","year":"2009","unstructured":"Udar N.; Atilano S.R.; Memarzadeh M.; Boyer D.S.; Chwa M.; Lu S.; Maguen B.; Langberg J.; Coskun P.; Wallace D.C.; Nesburn A.B.; Khatibi N.; Hertzog D.; Le K.; Hwang D.; Kenney M.C.; Mitochondrial DNA haplogroups associated with age-related macular degeneration. Invest Ophthalmol Vis Sci 2009,50(6),2966-2974","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1136\/bjo.63.3.169","volume":"63","author":"Slamovits T.L.","year":"1979","unstructured":"Slamovits T.L.; Mondzelewski J.P.; Kennerdell J.S.; Thyroid carcinoma metastatic to the globe. Br J Ophthalmol 1979,63(3),169-172","journal-title":"Br J Ophthalmol"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.survophthal.2007.06.006","volume":"52","author":"Arat Y.O.","year":"2007","unstructured":"Arat Y.O.; Boniuk M.; Red lesions of the iris, choroid, and skin secondary to metastatic carcinoma of the thyroid: a review. Surv Ophthalmol 2007,52(5),523-528","journal-title":"Surv Ophthalmol"},{"key":"ref=105","first-page":"81","volume":"51","author":"Singh U.","year":"2003","unstructured":"Singh U.; Kaushik S.; Pandav S.S.; Dogra M.R.; Powari M.; Das A.; Hemachandra M.; Papillary carcinoma thyroid presenting as a choroidal metastasis. Report of a case and brief review of literature. Indian J Ophthalmol 2003,51(1),81-83","journal-title":"Indian J Ophthalmol"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3322\/CA.2007.0010","volume":"58","author":"Jemal A.","year":"2008","unstructured":"Jemal A.; Siegel R.; Ward E.; Hao Y.; Xu J.; Murray T.; Thun M.; J. Cancer statistics, 2008. CA Cancer J Clin 2008,58(2),71-96","journal-title":"CA Cancer J Clin"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"5303","DOI":"10.1210\/jc.2004-0757","volume":"89","author":"Avram A.M.","year":"2004","unstructured":"Avram A.M.; Gielczyk R.; Su L.; Vine A.K.; Sisson J.C.; Choroidal and skin metastases from papillary thyroid cancer: case and a review of the literature. J Clin Endocrinol Metab 2004,89(11),5303-5307","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/S0002-9610(97)00158-X","volume":"174","author":"Shaha A.R.","year":"1997","unstructured":"Shaha A.R.; Shah J.P.; Loree T.R.; Differentiated thyroid cancer presenting initially with distant metastasis. Am J Surg 1997,174(5),474-476","journal-title":"Am J Surg"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/S0027-9684(15)31183-4","volume":"100","author":"Bucerius J.","year":"2008","unstructured":"Bucerius J.; Meyka S.; Michael B.; Biersack H.J.; Eter N.; Papillary thyroid carcinoma with an uncommon spread of hematogenous metastases to the choroid and the skin. J Natl Med Assoc 2008,100(1),104-107","journal-title":"J Natl Med Assoc"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1743-7563.2010.01332.x","volume":"7","author":"Tran K.","year":"2011","unstructured":"Tran K.; Bigby K.J.; Hughes B.G.; Lee L.; Allison R.; Clinicopathological report: bilateral choroidal metastases from papillary thyroid cancer. Asia Pac J Clin Oncol 2011,7(1),11-14","journal-title":"Asia Pac J Clin Oncol"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1089\/thy.2014.0511","volume":"25","author":"Makhija C.","year":"2015","unstructured":"Makhija C.; Su Y.B.; Goldner W.; Unusual Case of Papillary Thyroid Carcinoma with Choroidal Metastasis. Thyroid 2015,25(7),860-864","journal-title":"Thyroid"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1002\/cncr.20081","volume":"100","author":"D\u2019Avanzo A.","year":"2004","unstructured":"D\u2019Avanzo A.; Treseler P.; Ituarte P.H.G.; Wong M.; Streja L.; Greenspan F.S.; Siperstein A.E.; Duh Q.Y.; Clark O.H.; Follicular thyroid carcinoma: histology and prognosis. Cancer 2004,100(6),1123-1129","journal-title":"Cancer"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1634\/theoncologist.2010-0405","volume":"16","author":"McHenry C.R.","year":"2011","unstructured":"McHenry C.R.; Phitayakorn R.; Follicular adenoma and carcinoma of the thyroid gland. Oncologist 2011,16(5),585-593","journal-title":"Oncologist"},{"key":"ref=114","first-page":"191","volume":"33","author":"Betharia S.M.","year":"1985","unstructured":"Betharia S.M.; Metastatic orbital carcinoma of thyroid. Indian J Ophthalmol 1985,33(3),191-193","journal-title":"Indian J Ophthalmol"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s12070-007-0052-z","volume":"59","author":"Shyla P.R.","year":"2007","unstructured":"Shyla P.R.; Nair R.M.; Somanathan T.; Rare case of orbital tumor. Indian J Otolaryngol Head Neck Surg 2007,59(2),174-175","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/BF00935717","volume":"228","author":"Bernstein-Lipschitz L.","year":"1990","unstructured":"Bernstein-Lipschitz L.; Lahav M.; Chen V.; Gutman I.; Gal R.; Lipschitz M.; Metastatic thyroid carcinoma masquerading as lacrimal gland tumor. Graefes Arch Clin Exp Ophthalmol 1990,228(2),112-115","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1089\/thy.2005.15.1311","volume":"15","author":"Boughattas S.","year":"2005","unstructured":"Boughattas S.; Chatti K.; Degdegui M.; Bouslama Z.; Elaouni C.; Uncommon case of orbital metastasis secondary to papillary thyroid carcinoma. Thyroid 2005,15(11),1311-1312","journal-title":"Thyroid"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1089\/thy.2000.10.189","volume":"10","author":"Daumerie C.","year":"2000","unstructured":"Daumerie C.; De Potter P.; Godfraind C.; Rahier J.; Jamar F.; Squifflet J.P.; Orbital metastasis as primary manifestation of thyroid carcinoma. Thyroid 2000,10(2),189-192","journal-title":"Thyroid"},{"key":"ref=119","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2014-208870","volume":"2015","author":"Pagsisihan D.A.","year":"2015","unstructured":"Pagsisihan D.A.; Aguilar A.H.I.; Maningat M.P.D.D.; Orbital metastasis as initial manifestation of a widespread papillary thyroid microcarcinoma. BMJ Case Rep 2015,2015","journal-title":"BMJ Case Rep"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/RLU.0b013e3181d62752","volume":"35","author":"Malhotra G.","year":"2010","unstructured":"Malhotra G.; Upadhye T.S.; Menon S.; Asopa R.V.; Laskar S.G.; Pawar S.; Bhagat J.K.; Joshi P.; Unilateral proptosis due to orbital metastasis as a presenting clinical manifestation of carcinoma of the thyroid. Clin Nucl Med 2010,35(5),362-365","journal-title":"Clin Nucl Med"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/BF00181773","volume":"230","author":"Tijl J.","year":"1992","unstructured":"Tijl J.; Koornneef L.; Eijpe A.; Thomas L.; Gonzalez D.G.; Veenhof C.; Metastatic tumors to the orbit--management and prognosis. Graefes Arch Clin Exp Ophthalmol 1992,230(6),527-530","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0039-6257(90)90045-W","volume":"35","author":"Goldberg R.A.","year":"1990","unstructured":"Goldberg R.A.; Rootman J.; Cline R.A.; Tumors metastatic to the orbit: a changing picture. Surv Ophthalmol 1990,35(1),1-24","journal-title":"Surv Ophthalmol"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/S0161-6420(90)32534-4","volume":"97","author":"Goldberg R.A.","year":"1990","unstructured":"Goldberg R.A.; Rootman J.; Clinical characteristics of metastatic orbital tumors. Ophthalmology 1990,97(5),620-624","journal-title":"Ophthalmology"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1001\/archopht.1979.01020020057013","volume":"97","author":"Kennerdell J.S.","year":"1979","unstructured":"Kennerdell J.S.; Dekker A.; Johnson B.L.; Dubois P.J.; Fine-needle aspiration biopsy. Its use in orbital tumors. Arch Ophthalmol 1979,97(7),1315-1317","journal-title":"Arch Ophthalmol"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.amjmed.2004.11.028","volume":"118","author":"Basaria S.","year":"2005","unstructured":"Basaria S.; Cooper D.S.; Amiodarone and the thyroid. Am J Med 2005,118(7),706-714","journal-title":"Am J Med"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1136\/pgmj.62.732.909","volume":"62","author":"Wiersinga W.M.","year":"1986","unstructured":"Wiersinga W.M.; Trip M.D.; Amiodarone and thyroid hormone metabolism. Postgrad Med J 1986,62(732),909-914","journal-title":"Postgrad Med J"},{"key":"ref=127","first-page":"240","volume":"22","author":"Martino E.","year":"2001","unstructured":"Martino E.; Bartalena L.; Bogazzi F.; Braverman L.E.; The effects of amiodarone on the thyroid. Endocr Rev 2001,22(2),240-254","journal-title":"Endocr Rev"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1530\/EJE-17-0018","volume":"177","author":"Benjamens S.","year":"2017","unstructured":"Benjamens S.; Dullaart R.P.F.; Sluiter W.J.; Rienstra M.; van Gelder I.C.; Links T.P.; The clinical value of regular thyroid function tests during amiodarone treatment. Eur J Endocrinol 2017,177(1),9-14","journal-title":"Eur J Endocrinol"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1001\/archinte.1994.00420230115013","volume":"154","author":"Martino E.","year":"1994","unstructured":"Martino E.; Aghini-Lombardi F.; Bartalena L.; Grasso L.; Loviselli A.; Velluzzi F.; Pinchera A.; Braverman L.E.; Enhanced susceptibility to amiodarone-induced hypothyroidism in patients with thyroid autoimmune disease. Arch Intern Med 1994,154(23),2722-2726","journal-title":"Arch Intern Med"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s10741-008-9131-9","volume":"15","author":"Wiersinga W.M.","year":"2010","unstructured":"Wiersinga W.M.; The role of thyroid hormone nuclear receptors in the heart: evidence from pharmacological approaches. Heart Fail Rev 2010,15(2),121-124","journal-title":"Heart Fail Rev"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1210\/jc.2010-0180","volume":"95","author":"Bogazzi F.","year":"2010","unstructured":"Bogazzi F.; Bartalena L.; Martino E.; Approach to the patient with amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab 2010,95(6),2529-2535","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/j.1365-2265.2011.04087.x","volume":"75","author":"Ahmed S.","year":"2011","unstructured":"Ahmed S.; Van Gelder I.C.; Wiesfeld A.C.; Van Veldhuisen D.J.; Links T.P.; Determinants and outcome of amiodarone-associated thyroid dysfunction. Clin Endocrinol (Oxf) 2011,75(3),388-394","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1253\/circj.CJ-13-0220","volume":"77","author":"Yagishita A.","year":"2013","unstructured":"Yagishita A.; Hachiya H.; Kawabata M.; Nakamura T.; Sugiyama K.; Tanaka Y.; Sasano T.; Isobe M.; Hirao K.; Amiodarone-induced thyrotoxicosis late after amiodarone withdrawal. Circ J 2013,77(12),2898-2903","journal-title":"Circ J"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1001\/archopht.1983.01040020556010","volume":"101","author":"Flach A.J.","year":"1983","unstructured":"Flach A.J.; Dolan B.J.; Sudduth B.; Weddell J.; Amiodarone-induced lens opacities. Arch Ophthalmol 1983,101(10),1554-1556","journal-title":"Arch Ophthalmol"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1001\/archopht.1982.01030030603011","volume":"100","author":"Kaplan L.J.","year":"1982","unstructured":"Kaplan L.J.; Cappaert W.E.; Amiodarone keratopathy. Correlation to dosage and duration. Arch Ophthalmol 1982,100(4),601-602","journal-title":"Arch Ophthalmol"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/S0039-6257(97)00118-5","volume":"42","author":"M\u00e4ntyj\u00e4rvi M.","year":"1998","unstructured":"M\u00e4ntyj\u00e4rvi M.; Tuppurainen K.; Ik\u00e4heimo K.; Ocular side effects of amiodarone. Surv Ophthalmol 1998,42(4),360-366","journal-title":"Surv Ophthalmol"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1001\/archopht.1981.03930010259007","volume":"99","author":"D\u2019Amico D.J.","year":"1981","unstructured":"D\u2019Amico D.J.; Kenyon K.R.; Ruskin J.N.; Amiodarone keratopathy: drug-induced lipid storage disease. Arch Ophthalmol 1981,99(2),257-261","journal-title":"Arch Ophthalmol"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1097\/01.icu.0000143688.45232.15","volume":"15","author":"Hollander D.A.","year":"2004","unstructured":"Hollander D.A.; Aldave A.J.; Drug-induced corneal complications. Curr Opin Ophthalmol 2004,15(6),541-548","journal-title":"Curr Opin Ophthalmol"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1001\/archopht.1987.01060030069028","volume":"105","author":"Gittinger J.W.","year":"1987","unstructured":"Gittinger J.W.; Asdourian G.K.; Papillopathy caused by amiodarone. Arch Ophthalmol 1987,105(3),349-351","journal-title":"Arch Ophthalmol"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1136\/bjo.66.10.676","volume":"66","author":"Ingram D.V.","year":"1982","unstructured":"Ingram D.V.; Jaggarao N.S.; Chamberlain D.A.; Ocular changes resulting from therapy with amiodarone. Br J Ophthalmol 1982,66(10),676-679","journal-title":"Br J Ophthalmol"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/S2213-8587(13)70086-X","volume":"1","author":"Cooper D.S.","year":"2013","unstructured":"Cooper D.S.; Laurberg P.; Hyperthyroidism in pregnancy. Lancet Diabetes Endocrinol 2013,1(3),238-249","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1210\/jcem.86.6.7573","volume":"86","author":"Mandel S.J.","year":"2001","unstructured":"Mandel S.J.; Cooper D.S.; The use of antithyroid drugs in pregnancy and lactation. J Clin Endocrinol Metab 2001,86(6),2354-2359","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1517\/14740338.5.1.107","volume":"5","author":"Azizi F.","year":"2006","unstructured":"Azizi F.; The safety and efficacy of antithyroid drugs. Expert Opin Drug Saf 2006,5(1),107-116","journal-title":"Expert Opin Drug Saf"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1210\/jc.2015-4274","volume":"101","author":"Andersen S.L.","year":"2016","unstructured":"Andersen S.L.; Olsen J.; Laurberg P.; Antithyroid drug side effects in the population and in pregnancy. J Clin Endocrinol Metab 2016,101(4),1606-1614","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"E337","DOI":"10.1210\/jc.2010-0652","volume":"95","author":"Clementi M.","year":"2010","unstructured":"Clementi M.; Di Gianantonio E.; Cassina M.; Leoncini E.; Botto L.D.; Mastroiacovo P.; Treatment of hyperthyroidism in pregnancy and birth defects. J Clin Endocrinol Metab SAFE-Med Study Group2010,95(11),E337-E341","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=146","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/ajmg.a.30418","volume":"132A","author":"Foulds N.","year":"2005","unstructured":"Foulds N.; Walpole I.; Elmslie F.; Mansour S.; Carbimazole embryopathy: an emerging phenotype. Am J Med Genet 2005,132A(2),130-135","journal-title":"Am J Med Genet"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"4373","DOI":"10.1210\/jc.2013-2831","volume":"98","author":"Andersen S.L.","year":"2013","unstructured":"Andersen S.L.; Olsen J.; Wu C.S.; Laurberg P.; Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study. J Clin Endocrinol Metab 2013,98(11),4373-4381","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"C1","DOI":"10.1530\/EJE-14-0524","volume":"171","author":"Andersen S.L.","year":"2014","unstructured":"Andersen S.L.; Laurberg P.; Antithyroid drugs and congenital heart defects: ventricular septal defect is part of the methimazole\/carbimazole embryopathy. Eur J Endocrinol 2014,171(5),C1-C3","journal-title":"Eur J Endocrinol"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"R13","DOI":"10.1530\/EJE-14-0135","volume":"171","author":"Laurberg P.","year":"2014","unstructured":"Laurberg P.; Andersen S.L.; Therapy of endocrine disease: antithyroid drug use in early pregnancy and birth defects: time windows of relative safety and high risk? Eur J Endocrinol 2014,171(1),R13-R20","journal-title":"Eur J Endocrinol"},{"key":"ref=150","first-page":"3633","volume":"82","author":"Momotani N.","year":"1997","unstructured":"Momotani N.; Noh J.Y.; Ishikawa N.; Ito K.; Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves\u2019 hyperthyroidism. J Clin Endocrinol Metab 1997,82(11),3633-3636","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nrendo.2011.34","volume":"7","author":"Bliddal S.","year":"2011","unstructured":"Bliddal S.; Rasmussen A.K.; Sundberg K.; Brocks V.; Feldt-Rasmussen U.; Antithyroid drug-induced fetal goitrous hypothyroidism. Nat Rev Endocrinol 2011,7(7),396-406","journal-title":"Nat Rev Endocrinol"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1664:AID-CNCR23>3.0.CO;2-G","volume":"83","author":"Chang A.E.","year":"1998","unstructured":"Chang A.E.; Karnell L.H.; Menck H.R.; The American College of Surgeons Commission on Cancer and the American Cancer Society. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. Cancer 1998,83(8),1664-1678","journal-title":"Cancer"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"vii86","DOI":"10.1093\/annonc\/mds229","volume":"23","author":"Dummer R.","year":"2012","unstructured":"Dummer R.; Hauschild A.; Guggenheim M.; Keilholz U.; Pentheroudakis G.; Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol ESMO Guidelines Working Group2012,23(Suppl. 7),vii86-vii91","journal-title":"Ann Oncol"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/PPO.0000000000000186","volume":"22","author":"Dadu R.","year":"2016","unstructured":"Dadu R.; Zobniw C.; Diab A.; Managing adverse events with immune checkpoint agents. Cancer J 2016,22(2),121-129","journal-title":"Cancer J"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1210\/jc.2012-4075","volume":"98","author":"Corsello S.M.","year":"2013","unstructured":"Corsello S.M.; Barnabei A.; Marchetti P.; De Vecchis L.; Salvatori R.; Torino F.; Endocrine side effects induced by immune checkpoint inhibitors. J Clin Endocrinol Metab 2013,98(4),1361-1375","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Endocrine, Metabolic &amp; Immune Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/172714","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T04:27:09Z","timestamp":1581395229000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/172714\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,7]]},"references-count":155,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1,7]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871530319666190618120107","relation":{},"ISSN":["1871-5303"],"issn-type":[{"value":"1871-5303","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1,7]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-02-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-25","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}